A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA)

Abstract

Vortioxetine reduced depression severity and improved cognitive function, work productivity, and functioning in Taiwanese patients with MDD in the real-world setting. Vortioxetine was well-tolerated in this Taiwanese population.